Price Chart

Profile

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates:  LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
URL https://www.citiuspharma.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Feb. 14, 2025 (est.)
Last Earnings Release Aug. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates:  LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
URL https://www.citiuspharma.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Feb. 14, 2025 (est.)
Last Earnings Release Aug. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A